CAS No. :	783355-60-2
Formula :	C₂₁H₂₃N₃O₅
M.W :	397.42
SMILES Code :	O=C(C1=C(CN(C)C)C2=CC=CC=C2O1)NCCOC3=CC=C(C(NO)=O)C=C3
Synonyms :	Pci-24781; CRA 024781; CRA-24781
MDL No. :	MFCD10565969
InChI Key :	MAUCONCHVWBMHK-UHFFFAOYSA-N
Pubchem ID :	11749858

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H302-H315-H319-H335
Precautionary Statements:	P261-P305+P351+P338

Human CD34+ cells	10 to 100 nM	24 hours	Abexinostat inhibited CFU-MK growth, megakaryocyte (MK) proliferation and differentiation. These effects required only a short incubation period.	Cell Death Dis. 2013 Jul 25;4(7):e738.
Human skeletal (mesenchymal) stem cells (hMSCs)	500 nM	24 hours	Abexinostat promoted adipocytic differentiation of hMSCs by inducing the expression of several proadipocytic genes and significantly increasing the enrichment of the H3K9Ac epigenetic mark on the promoter regions of AdipoQ, FABP4, PPARγ, KLF15, CEBPA, SP7, and ALPL.	Stem Cells Transl Med. 2016 Aug;5(8):1036-47.
HCT116 colon cancer cells	0.2 µM, 0.5 µM, 1.0 µM	24 hours	To measure the effect of PCI-24781 on RAD51 protein levels, results showed a significant decrease in RAD51 protein levels by 24 hours.	Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19482-7.
MDA-MB-231	30 µM	48 hours	To screen for epigenetic small molecule inhibitors with anti-tumor activity	Theranostics. 2021 Jan 1;11(5):2058-2076.
Ramos cells	0.5 µM to 2.0 µM	48 hours	PCI-24781 induced concentration-dependent apoptosis in Ramos cells with an IC50 of 0.5 μM	Clin Cancer Res. 2009 May 15;15(10):3354-65.
SUDHL4 cells	0.5 µM to 2.0 µM	48 hours	PCI-24781 induced concentration-dependent apoptosis in SUDHL4 cells with an IC50 of 0.8 μM	Clin Cancer Res. 2009 May 15;15(10):3354-65.
HF1 cells	0.5 µM to 2.0 µM	48 hours	PCI-24781 induced concentration-dependent apoptosis in HF1 cells with an IC50 of 0.9 μM	Clin Cancer Res. 2009 May 15;15(10):3354-65.
L428 cells	0.5 µM to 2.0 µM	48 hours	PCI-24781 induced concentration-dependent apoptosis in L428 cells with an IC50 of 1.4 μM	Clin Cancer Res. 2009 May 15;15(10):3354-65.
U87	0.5–1.25 µM	48 hours	To evaluate the inhibitory effect of PCI-24781 on GBM cell proliferation, results showed that PCI-24781 significantly inhibited the proliferation of U87 cells.	J Exp Clin Cancer Res. 2021 Oct 25;40(1):335.
U251	0.5–1.25 µM	48 hours	To evaluate the inhibitory effect of PCI-24781 on GBM cell proliferation, results showed that PCI-24781 significantly inhibited the proliferation of U251 cells.	J Exp Clin Cancer Res. 2021 Oct 25;40(1):335.
U-118MG	0.5–1.25 µM	48 hours	To evaluate the inhibitory effect of PCI-24781 on GBM cell proliferation, results showed that PCI-24781 significantly inhibited the proliferation of U-118MG cells.	J Exp Clin Cancer Res. 2021 Oct 25;40(1):335.
DRAA8/CHO cells	2.0 µM, 3.0 µM	6 hours	To determine the effect of PCI-24781 on homologous recombinational repair, results showed that 2.0 µM and 3.0 µM PCI-24781 reduced the recombination frequency to 0.27% and 0.16%, respectively.	Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19482-7.
MDA-MB-231	3 µM	72 hours	To screen for inhibitors that can kill cancer cells with high efficiency	Theranostics. 2021 Jan 1;11(5):2058-2076.
MDA-MB-231	0.3 µM and 0.15 µM	72 hours	To explore the most effective inhibitor at a low dose	Theranostics. 2021 Jan 1;11(5):2058-2076.

Mice	GBM mouse model	Oral	12.5 mg/kg	BID, 5 days a week for 4 weeks	To evaluate the inhibitory effect of PCI-24781 on GBM tumor growth in vivo, results showed that PCI-24781 significantly reduced tumor burden and increased survival.	J Exp Clin Cancer Res. 2021 Oct 25;40(1):335.
BALB/c Nude mice	HCT116 colon cancer xenograft model	Oral	200 mg/kg	1×, 2×, or 3× over 4, 22, and 28 hours, respectively	To examine the effect of PCI-24781 on RAD51 protein levels in tumors, results showed a 69% decrease in RAD51 protein levels after 3 doses over 28 hours.	Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19482-7.
Nude mice	MDA-MB-231 xenograft model	Intravenous injection	50 mg/kg	Every other day for four weeks	To evaluate the anti-tumor effect of PCI-24781 in vivo	Theranostics. 2021 Jan 1;11(5):2058-2076.
Rats	Sprague-Dawley rats	Oral	8.00 mg/kg	Single dose	To study the pharmacokinetic properties of Abexinostat in rats, the results showed that after oral administration, the absorption was rapid, the maximum plasma concentration (Cmax) was 28.20 ± 7.67 ng/mL, the time to peak (Tmax) was about 1.39 ± 1.29 h, and the half-life (t1/2) was 13.80 ± 2.50 h.	BMC Chem. 2024 Feb 20;18(1):37

NCT03934567	Lymphoma, Follicular	PHASE2	RECRUITING	2024-09-30	Cancer Hospital Chinese Academ... More >>y of Medical Sciences, Beijing, 100021, China\|China-Japan Friendship Hospital, Beijing, 100029, China\|Peking University Third Hospital, Beijing, 100191, China\|Jilin Cancer Hospital, Changchun, 130012, China\|West China Hospital, Sichuan University, Chengdu, 610041, China\|The First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China\|Fujian Medical University Union Hospital, Fuzhou, 350001, China\|Cancer Center of Guangzhou Medical University, Guangzhou, 510030, China\|Sun Yai-Sen Memorial Hospital, Sun Yai-Sen University, Guangzhou, 510120, China\|Nanfang Hospital, Guangzhou, 510515, China\|Hainan General Hospital, Hainan, 570311, China\|The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, 310009, China\|Sir Run Run Shaw Hospital, Zhejiang University School of Medical, Hangzhou, 310020, China\|Zhejiang Cancer Hospital, Hangzhou, 310022, China\|The Affiliated Tumor Hospital of Harbin Medical University, Harbin, 150081, China\|The First Hospital of Lanzhou University, Lanzhou, 730000, China\|Linyi Cancer Hospital, Linyi, 276000, China\|Nantong Tumor Hospital, Nantong, 226361, China\|Shanghai Sixth people's hospital, Shanghai, 200025, China\|Fudan University Shanghai Cancer Center, Shanghai, 200032, China\|The Forth Hospital of Hebei Medical University, Shijiazhuang, 050011, China\|Tianjin People's Hospital, Tianjin, 300000, China\|Tianjin Medical University General Hospital, Tianjin, 300052, China\|The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, China\|Henan Cancer Hospital, Zhengzhou, 450008, China\|The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China Less <<
NCT04024696	Non Hodgkin Lymphoma	PHASE1\|PHASE2	ACTIVE_NOT_RECRUITING	2024-06-30	Cancer Hospital Chinese Academ... More >>y of Medical Sciences, Beijing, 100021, China\|Zhejiang Cancer Hospital, Hangzhou, 310022, China\|Tianjin Medical University General Hospital, Tianjin, 300052, China\|The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221006, China Less <<
NCT03600441	Follicular Lymphoma	PHASE2	ACTIVE_NOT_RECRUITING	2025-12-31	Advocate Medical Group - Park ... More >>Ridge, Luther Lane - Oncology, Park Ridge, Illinois, 60068, United States\|Norton Cancer Institute - St. Matthews Campus, Louisville, Kentucky, 40207, United States\|Clinical Research Alliance Inc, Lake Success, New York, 11042, United States\|Manhattan Hematology Oncology Center, New York, New York, 10016, United States\|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States\|Bone Marrow Transplant Hematology Oncology Associates, Pittsburgh, Pennsylvania, 15224-2156, United States\|Arlington Cancer Center, Arlington, Texas, 76012, United States\|Central Texas Veterans Health Care System - NAVREF, Temple, Texas, 76504, United States\|Vista Oncology Inc. PS, Olympia, Washington, 98506, United States\|Centre Hospitalier de Perpignan, Perpignan, Pyrénées-Orientales, 66046, France\|Hospital Universitario de Donostia, Donostia-San Sebastián, Guipúzcoa, 20014, Spain\|Hospital Universitario Vall d'Hebrón, Barcelona, 08035, Spain\|Hospital del Mar, Barcelona, 28229, Spain\|C.H. Regional Reina Sofia, Córdoba, 14004, Spain\|Hospital Universitario Infanta Leonor, Madrid, 28031, Spain Less <<
NCT00473577	Hematologic Neoplasms\|Neoplasm... More >>s Less <<	PHASE1	COMPLETED	2025-12-07	University of Chicago, Chicago... More >>, Illinois, 60643, United States Less <<

{[proInfo.proName]}

CAS No.: 783355-60-2

{[proInfo.proName]}

CAS No.: 783355-60-2

Alternative Products

Product Details of Abexinostat

Safety of Abexinostat

Related Pathways of Abexinostat

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	2.52mL 0.50mL 0.25mL	12.58mL 2.52mL 1.26mL	25.16mL 5.03mL 2.52mL
Dissolving Methods	Animal experiment The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed